Pretreatment Frequency of Circulating Th17 Cells and FeNO Levels Predicted the Real-World Response after 1 Year of Benralizumab Treatment in Patients with Severe Asthma

Benralizumab treatment reduces exacerbations and improves symptom control and quality of life in patients with severe eosinophilic asthma. However, the determination of biomarkers that predict therapeutic effectiveness is required for precision medicine. Herein, we elucidated the dynamics of various...

Full description

Saved in:
Bibliographic Details
Published inBiomolecules (Basel, Switzerland) Vol. 13; no. 3; p. 538
Main Authors Sandhu, Yuuki, Harada, Norihiro, Sasano, Hitoshi, Harada, Sonoko, Ueda, Shoko, Takeshige, Tomohito, Tanabe, Yuki, Ishimori, Ayako, Matsuno, Kei, Abe, Sumiko, Nagaoka, Tetsutaro, Ito, Jun, Chiba, Asako, Akiba, Hisaya, Atsuta, Ryo, Izuhara, Kenji, Miyake, Sachiko, Takahashi, Kazuhisa
Format Journal Article
LanguageEnglish
Published Switzerland MDPI AG 01.03.2023
MDPI
Subjects
Online AccessGet full text

Cover

Loading…